Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

被引：28
|
作者：
Chalhoub, Hussein [1 ]
Tunney, Michael [2 ]
Elborn, J. Stuart [2 ]
Vergison, Anne [3 ]
Denis, Olivier [4 ]
Plesiat, Patrick [5 ]
Kahl, Barbara C. [6 ]
Van Bambeke, Francoise [1 ]
Tulkens, Paul M. [1 ]
机构：
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium
[2] Queens Univ Belfast, CF & Airways Microbiol Res Grp, Belfast, Antrim, North Ireland
[3] Hop Univ Enfants Reine Fabiola, Unite Malad Infect, Brussels, Belgium
[4] Free Univ Brussels, Hop Erasme, Lab Microbiol, B-1070 Brussels, Belgium
[5] Hop Jean Minjoz, Lab Bacteriol, F-25030 Besancon, France
[6] Univ Hosp Munster, Med Microbiol, Munster, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2015年 / 70卷 / 05期
关键词：
carbapenemases; extended-spectrum beta-lactamases; ESBLs; beta-lactamase inhibition; P; aeruginosa; IN-VITRO ACTIVITY; EXACERBATIONS;
D O I：
10.1093/jac/dku551
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1596 / 1598
页数：4
相关论文
共 50 条
  • [41] In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis
    Mathy, Vincent
    Grohs, Patrick
    Compain, Fabrice
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (09) : 1217 - 1220
  • [42] Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Vrenna, Gianluca
    Trecca, Marika
    Assanti, Vanessa Tuccio Guarna
    Fiscarelli, Ersilia Vita
    Papa, Rosanna
    Selan, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [43] Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients
    Kidd, Timothy J.
    Ramsay, Kay A.
    Hu, Honghua
    Bye, Peter T. P.
    Elkins, Mark R.
    Grimwood, Keith
    Harbour, Colin
    Marks, Guy B.
    Nissen, Michael D.
    Robinson, Philip J.
    Rose, Barbara R.
    Sloots, Theo P.
    Wainwright, Claire E.
    Bell, Scott C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) : 1503 - 1509
  • [44] Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients
    Wagner, T
    Soong, G
    Sokol, S
    Saiman, L
    Prince, A
    CHEST, 2005, 128 (02) : 912 - 919
  • [45] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [46] ORAL COLONIZATION AND SUSCEPTIBILITY TESTING OF PSEUDOMONAS-AERUGINOSA ORAL ISOLATES FROM CYSTIC-FIBROSIS PATIENTS
    LINDEMANN, RA
    NEWMAN, MG
    KAUFMAN, AK
    LE, TV
    JOURNAL OF DENTAL RESEARCH, 1985, 64 (01) : 54 - 57
  • [47] Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Burns, JL
    Saiman, L
    Whittier, S
    Larone, D
    Krzewinski, J
    Liu, Z
    Marshall, SA
    JOnes, RN
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) : 1818 - 1822
  • [48] Enzyme polymorphism in Pseudomonas aeruginosa strains recovered from cystic fibrosis patients in France
    Martin, C
    Boyd, EF
    Quentin, R
    Massicot, P
    Selander, RK
    MICROBIOLOGY-UK, 1999, 145 : 2587 - 2594
  • [49] IN VITRO ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COLISTIN AGAINST CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES
    Hosbul, Tugrul
    Aydogan, Canset Nur
    Kaya, Sinem
    Bedir, Rhan
    Ozcan, Hande
    Gumral, Ramazan
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022, 85 (03): : 355 - 361
  • [50] MOXALACTAM-TOBRAMYCIN-RESISTANT PSEUDOMONAS-AERUGINOSA ISOLATES IN PATIENTS WITH CYSTIC-FIBROSIS
    FITZPATRICK, SB
    ROSENSTEIN, BJ
    CLINICAL PEDIATRICS, 1983, 22 (09) : 628 - 630
12345